Pharmaceuticals, Biotechnology and Life Sciences
San Diego-based Allele Biotechnology and Pharmaceuticals, Inc.,officially announced a joint research and development agreement withSouth Korea’s SCM Lifescience Co., Ltd., for the development of diabetestherapies using pancreatic beta cells derived from induced pluripotentstem cells (iPSCs).
DUBLIN–(BUSINESS WIRE)–The “Drugs of Abuse Testing: Technologies and Global Markets” report has been added to ResearchAndMarkets.com’s offering. Report Scope An…
Global Markets to 2023 with Abbott Laboratories, Bayer Healthcare, GlaxoSmithKline, Merck & Co, Pfizer and Sanofi at the Forefront
Librede hasbeen granted a new patent to produce tetrahydrocannabinolic acid (THCA)in yeast.
Promethera Biosciences’ Interim safety results and early efficacy signals with HepaStem bodewell for subsequent confirmatory trials in ACLF and provide valuableinsights for imminent start of clinical evaluation in NASH
Empagliflozin, in addition to standard of care, has the potential to improve economic outcomes for people with type 2 diabetes…
Shionogi presented data suggest cefiderocol shows a high potential for treating infections caused by themost difficult to treat Gram-negative (GN) bacteria collected fromacross Europe, including multidrug-resistant strains.
United States Foodand Drug Administration (FDA) has cleared the Company’s lead productcandidate, PLENITY (Gelesis100), as an aid in weight management inadults with a Body Mass Index (BMI) of 25–40 kg/m2, when usedin conjunction with diet and exercise.
Dr.Reddy’s has entered into a definitive agreement toacquire a portfolio of 42 approved, non-marketed Abbreviated New DrugApplications (ANDAs) in the U.S.
ASPECT-NP Clinical Trial Results Demonstrated Non-Inferiority of ZERBAXA to Meropenem for Treating Ventilated Nosocomial Pneumonia in Primary and Key Secondary…